Company
United StatesPublic company, OTC: VXRTVaxart, Inc. (OTC: VXRT), South San Francisco, CA – FDA Inspections
Inspection records and compliance data for Vaxart, Inc. in South San Francisco, California. 1 FDA inspection on record, last inspected September 22, 2022. Publicly traded as OTC: VXRT.
Company Profile
This profile covers Vaxart, Inc. based in South San Francisco, California, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected September 22, 2022.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| September 22, 2022 | NAI | Biologics · Bioresearch Monitoring | 1187525 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
CorneaGen, LLC
Tocagen Inc
Peter Charles Klatsky MD Inc
Central California Blood Center
Tissue Preservation Institute dba ZyGen Laboratory
Department of Defense - Air Force, Armed Services Whole Bld Processing Lab-West
Octapharma Plasma Inc
LifeStream Blood Bank
Blood Centers Of The Pacific- Redwood City Center
MedImmune, LLC
Company Information
Name
Vaxart, Inc.
Stock ticker
VXRT
Exchange
OTC
Price as of
November 6, 2026
FEI Number
3020962037
Address
170 Harbor Way Ste 300, South San Francisco, California 94080, United States
Country
United States
ID: 0f3b92b1-b937-4adb-bf37-92c82094e728